Unknown

Dataset Information

A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors.


ABSTRACT: The interaction between the eukaryotic translation initiation factor 4E (eIF4E) and eIF4E binding proteins (4E-BP) is a promising template for the inhibition of eIF4E and the treatment of diseases such as cancer and a spectrum of autism disorders, including the Fragile X syndrome (FXS). Here, we report an atomically detailed model of the complex between eIF4E and a peptide fragment of a 4E-BP, the cytoplasmic Fragile X interacting protein (CYFIP1). This model was generated using computer simulations with enhanced sampling from an alchemical replica exchange approach and validated using long molecular dynamics simulations. 4E-BP proteins act as post-transcriptional regulators by binding to eIF4E and preventing mRNA translation. Dysregulation of eIF4E activity has been linked to cancer, FXS,

SUBMITTER: Di Marino D 

PROVIDER: S-EPMC4570532 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature